4.4 Article

Clinical and Biological Factors Are Associated with Treatment-Resistant Depression

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Rheumatology

Patient Perception of Depressive Symptoms in Rheumatic Diseases A Cross-sectional Survey

Francesca Ingegnoli et al.

Summary: This study aimed to explore the presence and self-identification of depressive symptoms among patients with rheumatic musculoskeletal diseases. The results showed that 41.2% of the patients were diagnosed with clinical depression, while only 8.3% reported experiencing depressive symptoms.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2022)

Article Clinical Neurology

Exploring the role of serum lipid profile and neutrophil-to-lymphocyte ratio in violent suicide attempters: a cross sectional study

Enrico Capuzzi et al.

Summary: This study aimed to investigate the association between serum lipid levels, neutrophil/lymphocyte ratio (NLR), and violent suicide attempts in patients with mental disorders. The results showed that patients who used a violent suicide method had significantly lower levels of total cholesterol, LDL, VLDL, and NLR compared to those who used a nonviolent method.

CNS SPECTRUMS (2022)

Article Clinical Neurology

Factors associated with lifetime suicide attempts in bipolar disorder: results from an Italian nationwide study

Massimiliano Buoli et al.

Summary: This study found that factors associated with lifetime suicide attempts in bipolar disorder patients include age at first contact with psychiatric services, presence of psychotic symptoms or hospitalizations, attribution of symptoms to a psychiatric disorder, and receiving psychoeducation. Female patients showed an increased association with life-long suicidal behavior. These findings are significant for determining optimal management strategies for improving the prognosis of bipolar individuals exhibiting suicidal behavior.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2022)

Review Neurosciences

Vitamin E for the management of major depressive disorder: possible role of the anti-inflammatory and antioxidant systems

Luana M. Manosso et al.

Summary: Vitamin E has been found to play a role in the prevention and/or treatment of major depressive disorder (MDD) by modulating oxidative stress and neuroinflammation. This narrative review presents evidence from clinical and preclinical studies showing the relationship between low vitamin E status and MDD symptoms. More research is needed to determine the efficacy of vitamin E for alleviating depressive symptoms.

NUTRITIONAL NEUROSCIENCE (2022)

Article Nutrition & Dietetics

Associations Between Cholesterol and Fatty Acid Profile on the Severity of Depression in Older Persons With Nondialysis Chronic Kidney Disease

Massimiliano Buoli et al.

Summary: The study found that low-density lipoprotein levels and the arachidonic acid/linoleic acid ratio in serum lipid profile are significantly associated with the severity of depressive symptoms in CKD patients. Changing dietary habits or using hypocholesterolemic drugs may help prevent depressive symptoms.

JOURNAL OF RENAL NUTRITION (2021)

Article Multidisciplinary Sciences

Clinical characteristics of treatment-resistant depression in adults in Hungary: Real-world evidence from a 7-year-long retrospective data analysis

Peter Doeme et al.

Summary: This study aimed to estimate the proportion of TRD within Hungarian MDD patients and found that TRD patients have a higher risk of mortality and more comorbidities. A more comprehensive and targeted treatment strategy is needed for TRD patients.

PLOS ONE (2021)

Article Psychiatry

High neutrophil-lymphocyte ratio upon admission is associated with better response in psychotic depression

Vicent Llorca-Bofi et al.

Summary: Recent evidence suggests a relationship between the inflammatory system and mood disorders, with NLR potentially serving as a predictor of treatment response in PD patients.

JOURNAL OF PSYCHIATRIC RESEARCH (2021)

Article Psychiatry

Suicide prevention in psychiatric patients

Danuta Wasserman et al.

Summary: Psychiatric patients have an increased risk of suicide, with common conditions associated with suicidality including mood disorders, alcohol and substance use disorders, borderline personality disorder, and schizophrenia. Risk factors for suicide among psychiatric patients include a history of suicide attempts, feelings of hopelessness, impulsivity and aggression, adverse childhood experiences, severe psychopathology, and somatic disorders.

ASIA-PACIFIC PSYCHIATRY (2021)

Article Environmental Sciences

The Independent Role of Body Mass Index (BMI) and Severity of Depressive Symptoms on Biological Changes of Women Affected by Overweight/Obesity

Simona Iodice et al.

Summary: The study found associations between Body Mass Index (BMI), severity of depressive symptoms, and various biological abnormalities in women affected by overweight or obesity. Different biological changes were independently associated with BMI and severity of depression, highlighting the need for further research to better understand the complex interplay between overweight, depression, and biological changes.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Review Health Care Sciences & Services

Treatment-Resistant Depression Revisited: A Glimmer of Hope

Angelos Halaris et al.

Summary: MDD is a prevalent psychiatric disorder worldwide, with TRD causing significant impact on quality of life and suicide risk. Current pharmacologic interventions are ineffective for a portion of patients, leading to exploration of new approaches such as endocrinological aberrations and pharmacogenomic testing to address treatment resistance effectively.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Article Biochemistry & Molecular Biology

Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts

Chiara Fabbri et al.

Summary: Treatment-resistant depression (TRD) is a major contributor to the disability caused by major depressive disorder (MDD). This study demonstrated that MDD and TRD can be reliably defined using primary care records and provides the first large scale population assessment of the genetic, clinical and demographic characteristics of TRD.

MOLECULAR PSYCHIATRY (2021)

Review Biochemistry & Molecular Biology

Bilirubin: A Promising Therapy for Parkinson's Disease

Sri Jayanti et al.

Summary: With the increase in life expectancy, the prevalence of Parkinson's disease is expected to rise, but the diagnosis still relies on clinical symptoms. Current treatments mainly focus on alleviating symptoms without stopping or slowing down disease progression. Therefore, exploring the therapeutic potential of bilirubin in PD is crucial for the development of disease-modifying treatments.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Psychology, Clinical

The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States

Maryia Zhdanava et al.

Summary: This study evaluated the prevalence and burden of treatment-resistant depression (TRD) in the United States, finding that TRD accounted for a significant proportion of the burden of medication-treated major depressive disorder (MDD). The study highlighted the disproportionate health care costs and unemployment associated with TRD, suggesting potential economic and societal gains with effective management.

JOURNAL OF CLINICAL PSYCHIATRY (2021)

Review Psychology, Clinical

Defining treatment-resistant depression

Bradley N. Gaynes et al.

DEPRESSION AND ANXIETY (2020)

Review Clinical Neurology

Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines

Rachael W. Taylor et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)

Article

Association of clinical features and biomarkers with treatment-resistant depression

Ana Carolina Congio et al.

NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH (2020)

Article Environmental Sciences

The Association between Plasma ERVWE1 Concentrations and Affective Symptoms during Pregnancy: Is This a Friendly Alien?

Marta Serati et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Review Clinical Neurology

Management of Treatment-Resistant Depression: Challenges and Strategies

Daphne Voineskos et al.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2020)

Article Psychiatry

Treatment-resistant depression and peripheral C-reactive protein

Samuel R. Chamberlain et al.

BRITISH JOURNAL OF PSYCHIATRY (2019)

Review Clinical Neurology

The burden of treatment-resistant depression: A systematic review of the economic and quality of life literature

Karissa M. Johnston et al.

JOURNAL OF AFFECTIVE DISORDERS (2019)

Review Clinical Neurology

Inflammatory markers and treatment outcome in treatment resistant depression: A systematic review

Chenghao Yang et al.

JOURNAL OF AFFECTIVE DISORDERS (2019)

Review Mathematical & Computational Biology

Variable selection - A review and recommendations for the practicing statistician

Georg Heinze et al.

BIOMETRICAL JOURNAL (2018)

Review Clinical Neurology

Inflammatory markers and cortisol parameters across depressive subtypes in an older cohort

E. M. Veltman et al.

JOURNAL OF AFFECTIVE DISORDERS (2018)

Review Clinical Neurology

Treatment-resistant depression and suicidality

Isidoor O. Bergfeld et al.

JOURNAL OF AFFECTIVE DISORDERS (2018)

Review Clinical Neurology

Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: A meta-analysis

Mario Gennaro Mazza et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)

Review Clinical Neurology

Suggested Biomarkers for Major Depressive Disorder

Yunus Hacimusalar et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY (2018)

Article Endocrinology & Metabolism

Oxidative stress, inflammation and treatment response in major depression

Daniel Lindqvist et al.

PSYCHONEUROENDOCRINOLOGY (2017)

Review Clinical Neurology

Perinatal Major Depression Biomarkers: A systematic review

M. Serati et al.

JOURNAL OF AFFECTIVE DISORDERS (2016)

Article Multidisciplinary Sciences

The significance of routine biochemical markers in patients with major depressive disorder

You-Fan Peng et al.

SCIENTIFIC REPORTS (2016)

Review Clinical Neurology

Inflammation and clinical response to treatment in depression: A meta-analysis

R. Strawbridge et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)

Article Endocrinology & Metabolism

Is depression associated with increased oxidative stress? A systematic review and meta-analysis

Catherine N. Black et al.

PSYCHONEUROENDOCRINOLOGY (2015)

Article Multidisciplinary Sciences

A Meta-Analysis of Oxidative Stress Markers in Depression

Tao Liu et al.

PLOS ONE (2015)

Article Psychiatry

The impact of mood episodes and duration of illness on cognition in bipolar disorder

Massimiliano Buoli et al.

COMPREHENSIVE PSYCHIATRY (2014)

Review Clinical Neurology

Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach

Roger S. McIntyre et al.

JOURNAL OF AFFECTIVE DISORDERS (2014)

Article Pharmacology & Pharmacy

Age at onset and latency to treatment (duration of untreated illness) in patients with mood and anxiety disorders: a naturalistic study

Alfredo Carlo Altamura et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)

Article Psychiatry

Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder

Louis S. Matza et al.

INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH (2010)

Article Mathematical & Computational Biology

Purposeful selection of variables in logistic regression

Zoran Bursac et al.

SOURCE CODE FOR BIOLOGY AND MEDICINE (2008)

Article Psychology, Clinical

Lithium treatment reduces suicide risk in recurrent major depressive disorder

Francesca Guzzetta et al.

JOURNAL OF CLINICAL PSYCHIATRY (2007)

Article Psychiatry

Clinical implications of Brief Psychiatric Rating Scale scores

S Leucht et al.

BRITISH JOURNAL OF PSYCHIATRY (2005)

Article Clinical Neurology

Defining remission by cut off score on the MADRS: selecting the optimal value

CJ Hawley et al.

JOURNAL OF AFFECTIVE DISORDERS (2002)